Noteworthy

Feb 15, 2018
Pharmaceutical Executive
This article examines the key ways the new tax bill will impact the pharmaceutical industry.
Feb 12, 2018
Pharmaceutical Executive
The biotech sector has managed to elude the negative perceptions saddling traditional pharma these days. We examine the reasons why.
Feb 12, 2018
Pharmaceutical Executive
Lieutenant General (Ret) Rick Lynch, US Army, and Bob Jansen, CEO of Zensights, discuss the military-industry effort to instill the principles of adaptive leadership into today’s pharma leader.
Feb 12, 2018
Pharmaceutical Executive
Whether the pharma industry is navigating calm or choppy waters, it should be smarter and more assertive in telling its story to its stakeholders—most importantly, patients and the wider public.
Feb 11, 2018
Jin Zhang reviews the current fortunes of the Chinese pharmaceutical companies.
Feb 08, 2018
From Applied Clinical Trials
Keith Fern looks at how community clinics can be turned into research sites.
Feb 02, 2018
Pharmaceutical Executive
2017 was a year of swings and momentum for the pharma and biotech markets. Is more stable footing ahead? Peter Young reports.
Feb 01, 2018
In his State-of-the-Union address this week, President Trump continued his harangue about unfair drug prices in the U.S., but he surprised many observers by failing to call for full repeal of the Affordable Care Act.
Jan 31, 2018
Pharmaceutical Executive
Molly Harper, vice president of commercial development at Akcea Therapeutics, outlines best practices for this unique group of therapies
Jan 30, 2018
Improving the productivity of sponsors’ clinical development processes will continue to be a primary driver of outsourcing in 2018, writes Nuala Murphy.
native1_300x100
lorem ipsum